Citizen Petitions: FDA Sees Increase In Requests For Reconsideration, Serial Filings

FDA is concerned that the number of citizen petitions requesting reconsideration of agency decisions, the filing of serial petitions by the same firm, and requests from non-innovator companies could delay the approval of generics.